Comparison of hypertension management between cancer survivors and the general public
Hypertension Research, 04/27/2012Shin DW et al.
Cancer survivors appear to be better with antihypertensive medication adherence and blood pressure (BP) monitoring than those without cancer, and as a result, they appear to be under better BP control. However, several methodological limitations of the study prompt further research on this issue.
A nationwide, multicenter, cross–sectional survey was administered to adult cancer patients, currently receiving treatment or follow–up, who had been diagnosed with hypertension.
Comparison group was selected from among participants in the health behavior survey of the third Korean National Health and Nutrition Examination Survey.
Self–reported hypertension management was surveyed, including antihypertensive medication adherence, frequency of blood pressure (BP) monitoring and perceived BP control.
Multivariate logistic regression analysis was used to evaluate the relationship between cancer survivorship and each outcome measure.
Compared with the general population, cancer survivors were more likely to report full adherence (92.7% vs. 73.0%; adjusted odds ratio (aOR)=3.45; 95% confidence interval (CI), 2.08–5.73), more frequent BP measurement (24 per year: 50.1% vs. 24.7%; aOR=2.51; 95% CI, 1.83–3.46), and very good perceived BP control (60.8% vs. 26.2%; aOR=4.34; 95% CI, 3.13–6.02).
Cancer survivors appear to be better with antihypertensive medication adherence and BP monitoring than those without cancer, and as a result, they appear to be under better BP control.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.